Answers are grounded in this paper and cite their sources.
To the Editor: Methotrexate is effective in the treatment of a number of chronic diseases, such as Crohn's disease,1 but concern about long-term hepatotoxicity has limited its widespread use. Although elevated serum aminotransferase concentrations are often considered a reason for stopping methotrexate,1 there is little information about the nature or seriousness of the elevations and little, if any, correlation between them and liver histology. We report on a patient who had transient increases in serum aminotransferase values with unchanged liver histology while receiving methotrexate for primary sclerosing cholangitis. A 37-year-old man was referred to our center because of jaundice and . . .
No takes yet. Share an insight, caveat, or question.
Dufour et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: